Chemical Structure (Onivyde 01)
Onivyde Injection, Powder, For Solution
Product Images NDC 15054-0043
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Onivyde (NDC 15054-0043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ipsen Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Onivyde 02)
Principal Display Panel (43 mg/10 mL Vial Label)
This is a prescription drug with the name Onivyde. It is an injection with 43 mg/10 mL (4.3 mg/mL) dosage of irinotecan liposome. It is administered through intravenous infusion after dilution, and comes in a single-dose vial for which the unused portion should be discarded. It should not be substituted with Irinotecan Hydrochloride. It is a liposomal formulation and a cytotoxic agent. It should be stored in its original carton to protect it from light and refrigerated between 2°C to 8°C (36°F to 46°F) without freezing. Dosage and administration instructions are available in the package insert. It is manufactured by Ipsen Biopharmaceuticas, Inc. located in Cambridge, MA.*
Principal Display Panel (43 mg/10 mL Vial Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
